Decoding multiple sclerosis: An update on genomics and future directions

Expert Review of Neurotherapeutics

Volumn 13, Issue 12 SUPPL., 2013, Pages 11-19

  Oksenberg, Jorge R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

allelic variation; genetics; genomics; human genome; multiple sclerosis; susceptibility

Indexed keywords

CD40 ANTIGEN; CD6 ANTIGEN; CD86 ANTIGEN; FOCAL ADHESION KINASE 1; HLA DRB1 ANTIGEN; HLA DRB5 ANTIGEN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 22; INTERLEUKIN 7; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE TYK2; STAT3 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ALLELE; B LYMPHOCYTE; CHROMOSOME 6; CONFERENCE PAPER; DISEASE PREDISPOSITION; DNA MICROARRAY; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; FOLLOW UP; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC LOAD; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HELPER CELL; HEREDITY; HUMAN; INHERITANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOLAR RADIATION; VITAMIN D DEFICIENCY;

GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME; GENOMICS; HUMANS; MULTIPLE SCLEROSIS;

EID: 84890036481     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2013.865867     Document Type: Conference Paper

References (23)

1. Johnson BA, Oksenberg Jr. Chapter 235. 2. The role of genetics in multiple sclerosis. In: Scriver's Online Metabolic and Molecular Bases of Inherited Disease (OMMBID). Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A (Eds). McGraw-Hill, NY, USA (2012
2. International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357(9), 851-862 (2007
3. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145), 661-678 (2007
4. Comabella M, Craig DW, Camiña-Tato M et al. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3(10), e3490 (2008
5. Baranzini SE, Wang J, Gibson N et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet. 15: 767-778 (2009
6. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 41(7), 824-828 (2009
7. Jakkula E, Leppä V, Sulonen AM et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am. J. Hum. Genet. 86(2), 285-291 (2010
8. Sanna S, Pitzalis M, Zoledziewska M et al. Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat. Genet. 42(6), 495-497 (2010
9. International Multiple Sclerosis Genetics Consortium and Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359), 214-219 (2011
10. Matesanz F, González-Pérez A, Lucas M et al. Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PLoS ONE 7(5), e36140 (2012
11. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 9(7), 516-526 (2008
12. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13(1), 101 (2011
13. International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353-1360 (2013
14. Gourraud PA, McElroy JP, Caillier SJ et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann. Neurol. 69(1), 65-74 (2011
15. Isobe N, Gourraud PA, Harbo HF et al. Genetic risk variants in African Americans with multiple sclerosis. Neurology 81(3), 219-227 (2013
16. Gregory SG, Schmidt S, Seth P et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 39(9), 1083-1091 (2007
17. Maier LM, Lowe CE, Cooper J et al. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet. 5(1), e1000322 (2009
18. Gregory AP, Dendrou CA, Attfield KE et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488(7412), 508-511 (2012
19. De Jager PL, Baecher-Allan C, Maier LM et al. The role of the CD58 locus in multiple sclerosis. Proc. Natl Acad. Sci. USA 106(13), 5264-5269 (2009
20. De Jager PL, Jia X, Wang J et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41(7), 776-782 (2009
21. Couturier N, Bucciarelli F, Nurtdinov RN et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 134(Pt 3), 693-703 (2011
22. Kofler DM, Severson CA, Mousissian N, De Jager PL, Hafler DA. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation. J. Immunol. 187(6), 3286-3291 (2011
23. Martin D, Pantoja C, Fernandez-Minan A et al. Genome-wide CTCF distribution in vertebrates defines equivalent sites that aid the identification of disease-associated genes. Nat. Struct. Mol. Biol. 18(6), 708-715 (2011